Thyroid Disease
Conditions
Keywords
Near infrared fluorescence, ICG, Parathyroid gland
Brief summary
During surgery in which the thyroid is removed (thyroidectomy), the identification of parathyroid glands, that should be saved, can be challenging. Therefore, there is need for accurate intraoperative guidance. Earlier animal studies show that the parathyroid glands can be identified by the use of the Near Infrared Fluorescent dye Indocyanine green (ICG). Our hypothesis is therefore, that the use of ICG-based fluorescence imaging during thyroid surgery will provide real-time intraoperative visualization of the parathyroid glands. This prospective observational feasibility study aims to evaluate the feasibility of the use of ICG in identifying the parathyroid glands during thyroid surgery. 30 patients (age \>18 years) who are already regularly scheduled for thyroid surgery; i.e. patients undergoing total thyroidectomy are suitable for inclusion. In all patients, undergoing total thyroidectomy infrared fluorescence imaging, using a per-operative intravenous injection of 7.5 mg ICG, will be tested on feasibility and imaging characteristics.
Detailed description
In this study, the feasibility of the use of NIR fluorescence imaging for the identification of the parathyroid glands during thyroid surgery will be explored. Per-operatively: The surgery will start as usual. When the surgeon would normally search for the parathyroid glands, 7.5 mg of ICG will be administered intravenously through the infusion in the patients arm. An intravenous administration is chosen because of the minimal invasive nature and results of the described earlier case series in which ICG was also administered via peripheral infusion. Directly after that, the fluorescence system can be switched to fluorescence mode. The surgeon will determine whether the parathyroid glands are visible now. If needed, due to washout, a second dose of 7.5 mg of ICG can be administered. After identification of the parathyroid glands, surgery will continue as in the standard situation, until there is a desire to visualize the parathyroid glands again, then another dose of ICG can be given. Time until first identification of the parathyroid glands and total surgical time will be measured. After complete removal of the thyroid, another 7.5 mg of ICG will be administered intravenously to visualize the vascularization of the parathyroid gland. The intensity will be subjectively scored: 1 parathyroid black after injection of ICG, 2 partially vascularized, or 3 parathyroid is green; well vascularized. The fluorescence system will be used to record the whole procedure. Directly after the procedure the researcher will ask the surgeon whether he or she thinks the technique is feasible. Postoperatively: As in standard care, after thyroid surgery, the serum calcium levels will be determined. Low calcium levels can indicate misidentification of parathyroid glands. These calcium levels are determined only in patients after total thyroidectomy on day 1, 2 and after two weeks. Also TSH will be determined after two weeks as in standard care. The thyroid specimen will be send to pathology. In the specimen, the pathologist will search for parathyroid glands, as is standard care. Furthermore, video recordings will be analyzed, quantifying the fluorescence signal compared to the background: measuring the Target to Background Ratio. Also, in these video recordings the time until visualization of the parathyroid glands will be reassessed by an independent expert.
Interventions
DEVICENIRF imaging in thyroid surgery
a fluorescence imaging system and 7.5 mg of ICG will be used to visualize the parathyroids glands.
Sponsors
Maastricht University Medical Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female patients, aged 18 years and above * Scheduled for elective total or hemi thyroidectomy * Normal liver and renal function * No known hypersensitivity for iodine or ICG * Able to understand the nature of the study procedures * Willing to participate and give written informed consent
Exclusion criteria
* Age \< 18 years * Liver or renal insufficiency * Known ICG, iodine, penicillin or sulfa hypersensitivity * Pregnancy or breastfeeding * Not able to understand the nature of the study procedure * i.v. heparin injection in the last 24h (LMWH not contraindicated) * Not willing to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to identification of parathyroid glans | during surgery | Can the parathyroid glands be identified earlier with NIRF light? Time until identification in NIRF and white light will be compared. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total surgical time | From incision until closure | — |
| Histology: are parathyroid glands in the specimen? (as in standard care) | assessment within 1 week after surgery | immediately after surgery, the thyroid specimen will be send to the pathology department for histological examination as in standard care, with extra attention on wether there are parathyroid glands in the specimen. |
| Subjective opinion surgeon about the usefulness of the technique | Immediately after surgery | — |
| Intra-operative complications due to the use of the technique | during surgery | — |
Other
| Measure | Time frame | Description |
|---|---|---|
| Quantitative measurement of fluorescence signal related to parathyroid function | up to 2 weeks | Quantitative measurement of fluorescence signal using Target to Background Ratio (TBR) is used, combined with parameters of parathyroid function, namely Calcium levels postoperatively day 1 and day 2, and week 2 in patients after total thyroidectomy (as in standard care), and TSH in patients after total thyroidectomy 2 weeks postoperatively (as in standard care). |
Countries
Netherlands
Outcome results
None listed